10-Q: Acreage Holdings Reports Q3 2024 Results Amidst Strategic Shift and Pending Acquisition

Acreage Holdings reports a decrease in revenue and a net loss for Q3 2024, while navigating strategic changes and a pending acquisition by Canopy USA.

Summary

• Acreage Holdings reported a net loss of $19.5 million for the third quarter of 2024, compared to a loss of $7.6 million in the same period of 2023.
• The company's total revenue decreased by 30% to $39.6 million in Q3 2024, down from $56.5 million in Q3 2023, primarily due to liquidity constraints and competitive pressures.
• Retail revenue declined by 37% to $27.4 million, while wholesale revenue saw a smaller decrease of 4% to $12.2 million.
• Gross profit decreased by 35% to $13.9 million, with gross margin falling to 35% from 38% in the prior year.
• Operating expenses decreased by 5% to $22.6 million, driven by reductions in general and administrative and compensation expenses.
• The company's adjusted EBITDA was $0.6 million for Q3 2024, a significant decrease from $6.6 million in Q3 2023.
• For the nine months ended September 30, 2024, the net loss was $68.5 million, compared to $38.4 million in the same period of 2023.
• Total revenue for the first nine months of 2024 was $123.9 million, a 27% decrease from $170.6 million in 2023.
• The company's cash and cash equivalents stood at $13.8 million as of September 30, 2024.
• Acreage is preparing for a potential acquisition by Canopy USA, with the Canopy Call Option exercised on June 3, 2024, subject to closing conditions.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with significant revenue declines, increased losses, and a substantial decrease in EBITDA. While there are some positive developments like new market launches and financing activities, the overall sentiment is negative due to the company's financial struggles and going concern issues.

Positives

• Operating expenses decreased by 5% in Q3 2024, indicating some success in cost management.
• The company launched adult-use sales in Connecticut and Ohio, expanding its market reach.
• Acreage secured a private placement of 12,000 units for $10 million, providing additional capital.
• The company entered into a second amended and restated credit agreement, addressing previous defaults and securing a new loan.
• The company has made progress towards a potential acquisition by Canopy USA, with the Canopy Call Option exercised.

Negatives

• Total revenue decreased by 30% in Q3 2024, indicating a significant decline in sales.
• The net loss for Q3 2024 was $19.5 million, a substantial increase from the $7.6 million loss in Q3 2023.
• Adjusted EBITDA decreased significantly to $0.6 million in Q3 2024, down from $6.6 million in Q3 2023.
• Retail revenue declined by 37%, reflecting challenges in the retail sector.
• Gross profit decreased by 35%, and gross margin fell to 35%, indicating reduced profitability.
• The company's liquidity constraints limited its ability to purchase inventory, impacting revenue.
• The company experienced a $6,322 loss related to the extinguishment of the Prime rate credit facilities.

Risks

• The company faces substantial doubt about its ability to continue as a going concern due to accumulated deficits and negative cash flow.
• The pending acquisition by Canopy USA is subject to closing conditions, and there is no guarantee it will be completed.
• The company's operations are subject to evolving cannabis regulations, which could lead to fines or restrictions.
• Acreage is exposed to market, credit, liquidity, and interest rate risks.
• The company has a material weakness in internal controls over financial reporting, which could lead to misstatements.
• The company's debt obligations are significant, with $274.7 million outstanding as of September 30, 2024.
• The company's revenue is heavily reliant on U.S. cannabis operations, which are illegal under federal law.
• The company faces increasing competition and pricing pressures in its key markets.
• The company's financial performance is impacted by economic conditions and industry competition.

Future Outlook

The company is focused on maximizing cash flow, accelerating growth in core markets, and preparing for a potential acquisition by Canopy USA. The closing of the acquisition is subject to various conditions and there is no guarantee it will be completed.

Management Comments

• Management believes its focused strategy is key to continued improvements in financial results and shareholder value.
• The company is focused on maximizing cash flow generated by operating activities and limiting capital expenditures.
• Management believes Acreage is well-positioned for future success in several key markets as regulations regarding the use of cannabis continue to evolve.

Industry Context

The cannabis industry is facing increased competition and pricing pressures, impacting Acreage's revenue and profitability. The company's strategic shift towards core markets and brands reflects a broader trend in the industry to focus on profitability and sustainability. The pending acquisition by Canopy USA is part of a larger consolidation trend in the cannabis sector.

Comparison to Industry Standards

• Acreage's revenue decline of 30% in Q3 2024 is worse than some of its peers, who have shown more resilience in the face of market pressures. For example, Curaleaf reported a 2% increase in revenue in their most recent quarter.
• The company's gross margin of 35% is below the industry average, which is closer to 40-50% for established multi-state operators. Trulieve, for example, has consistently reported gross margins above 50%.
• Acreage's adjusted EBITDA of $0.6 million is significantly lower than other MSOs, such as Green Thumb Industries, which reported adjusted EBITDA of $78 million in their most recent quarter.
• The company's high debt load of $274.7 million is a concern compared to other MSOs with stronger balance sheets. Cresco Labs, for example, has a lower debt-to-equity ratio.
• The company's ongoing material weakness in internal controls is a significant concern, as it indicates a lack of robust financial reporting processes, which is not typical for publicly traded companies in the cannabis sector.

Legal Proceedings

• The company is involved in ongoing litigation with EPMMNY LLC, Health Circle, Inc., and Alfreds Finest, Inc.
• Acreage intends to vigorously defend against these actions, which it believes are without merit.

Related Party Transactions

• The company has ongoing transactions with Canopy Growth and its affiliates, including a secured debenture and credit facilities.
• Acreage is party to a tax receivable agreement with certain current and former unit holders of HSCP.

Stakeholder Impact

• Shareholders are negatively impacted by the company's poor financial performance and the potential dilution from the private placement.
• Employees may be affected by ongoing cost-cutting measures and potential restructuring.
• Customers may experience changes in product availability due to liquidity constraints.
• Creditors are exposed to the company's high debt load and going concern issues.
• Suppliers may face uncertainty due to the company's financial challenges.

Next Steps

• The company will focus on maximizing cash flow from operations.
• Acreage will continue to accelerate growth in core markets with core brands.
• The company will prepare for the potential acquisition by Canopy USA.
• Acreage will work to remediate the material weakness in internal controls over financial reporting.

Key Dates

Keywords

cannabis, Acreage Holdings, financial results, Q3 2024, revenue, net loss, EBITDA, retail, wholesale, Canopy USA, acquisition, debt, liquidity, going concern, internal controls